Effect of Tofogliflozin on Carotid Intima-Media Thickness in Patients with Type 2 Diabetes: Results from the Prospective, Randomized, Open-Label, Parallel-Group Comparative UTOPIA Trial

被引：0
|
作者：
Katakami, Naoto
Mita, Tomoya
Watada, Hirotaka
Shimomura, Iichiro
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-1116-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1116-P
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial
    Katakami, Naoto
    Mita, Tomoya
    Yoshii, Hidenori
    Shiraiwa, Toshihiko
    Yasuda, Tetsuyuki
    Okada, Yosuke
    Torimoto, Keiichi
    Umayahara, Yutaka
    Kaneto, Hideaki
    Osonoi, Takeshi
    Yamamoto, Tsunehiko
    Kuribayashi, Nobuichi
    Maeda, Kazuhisa
    Yokoyama, Hiroki
    Kosugi, Keisuke
    Ohtoshi, Kentaro
    Hayashi, Isao
    Sumitani, Satoru
    Tsugawa, Mamiko
    Ryomoto, Kayoko
    Taki, Hideki
    Nakamura, Tadashi
    Kawashima, Satoshi
    Sato, Yasunori
    Watada, Hirotaka
    Shimomura, Iichiro
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [2] Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial
    Naoto Katakami
    Tomoya Mita
    Hidenori Yoshii
    Toshihiko Shiraiwa
    Tetsuyuki Yasuda
    Yosuke Okada
    Keiichi Torimoto
    Yutaka Umayahara
    Hideaki Kaneto
    Takeshi Osonoi
    Tsunehiko Yamamoto
    Nobuichi Kuribayashi
    Kazuhisa Maeda
    Hiroki Yokoyama
    Keisuke Kosugi
    Kentaro Ohtoshi
    Isao Hayashi
    Satoru Sumitani
    Mamiko Tsugawa
    Kayoko Ryomoto
    Hideki Taki
    Tadashi Nakamura
    Satoshi Kawashima
    Yasunori Sato
    Hirotaka Watada
    Iichiro Shimomura
    Cardiovascular Diabetology, 20
  • [3] Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study
    Katakami, Naoto
    Mita, Tomoya
    Yoshii, Hidenori
    Shiraiwa, Toshihiko
    Yasuda, Tetsuyuki
    Okada, Yosuke
    Torimoto, Keiichi
    Umayahara, Yutaka
    Kaneto, Hideaki
    Osonoi, Takeshi
    Yamamoto, Tsunehiko
    Kuribayashi, Nobuichi
    Maeda, Kazuhisa
    Yokoyama, Hiroki
    Kosugi, Keisuke
    Ohtoshi, Kentaro
    Hayashi, Isao
    Sumitani, Satoru
    Tsugawa, Mamiko
    Ryomoto, Kayoko
    Taki, Hideki
    Nakamura, Tadashi
    Kawashima, Satoshi
    Sato, Yasunori
    Watada, Hirotaka
    Shimomura, Iichiro
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [4] Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study
    Naoto Katakami
    Tomoya Mita
    Hidenori Yoshii
    Toshihiko Shiraiwa
    Tetsuyuki Yasuda
    Yosuke Okada
    Keiichi Torimoto
    Yutaka Umayahara
    Hideaki Kaneto
    Takeshi Osonoi
    Tsunehiko Yamamoto
    Nobuichi Kuribayashi
    Kazuhisa Maeda
    Hiroki Yokoyama
    Keisuke Kosugi
    Kentaro Ohtoshi
    Isao Hayashi
    Satoru Sumitani
    Mamiko Tsugawa
    Kayoko Ryomoto
    Hideki Taki
    Tadashi Nakamura
    Satoshi Kawashima
    Yasunori Sato
    Hirotaka Watada
    Iichiro Shimomura
    Cardiovascular Diabetology, 19
  • [5] Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial
    Tanaka, Atsushi
    Sata, Masataka
    Okada, Yosuke
    Teragawa, Hiroki
    Eguchi, Kazuo
    Shimabukuro, Michio
    Taguchi, Isao
    Matsunaga, Kazuo
    Kanzaki, Yumiko
    Yoshida, Hisako
    Ishizu, Tomoko
    Ueda, Shinichiro
    Kitakaze, Masafumi
    Murohara, Toyoaki
    Node, Koichi
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (02) : 165 - 172
  • [6] Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes - A randomized trial
    Mazzone, Theodore
    Meyer, Peter M.
    Feinstein, Steven B.
    Davidson, Michael H.
    Kondos, George T.
    D'Agostino, Ralph B., Sr.
    Perez, Alfonso
    Provost, Jean-Claude
    Haffner, Steven M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (21): : 2572 - 2581
  • [7] Carotid intima-media thickness in patients with Type 2 diabetes and hypercholesterolemia
    Montecchi, FR
    Menzinger, G
    Lala, A
    DIABETES NUTRITION & METABOLISM, 2001, 14 (01) : 58 - 61
  • [8] Impact of Acarbose on Carotid Intima-Media Thickness in Patients With Newly Diagnosed Impaired Glucose Tolerance or Mild Type 2 Diabetes Mellitus: A One-Year, Prospective, Randomized, Open-Label, Parallel-Group Study in Japanese Adults With Established Coronary Artery Disease
    Koyasu, Masayoshi
    Ishii, Hideki
    Watarai, Masato
    Takemoto, Kenji
    Inden, Yasuya
    Takeshita, Kyosuke
    Amano, Tetsuya
    Yoshikawa, Daiji
    Matsubara, Tatsuaki
    Murohara, Toyoaki
    CLINICAL THERAPEUTICS, 2010, 32 (09) : 1610 - 1617
  • [9] Efficacy of a Digital Diabetes Logbook for People With Type 1, Type 2, and Gestational Diabetes: Results From a Multicenter, Open-Label, Parallel-Group, Randomized Controlled Trial
    Ehrmann, Dominic
    Hermanns, Norbert
    Finke-Groene, Katharina
    Roos, Timm
    Kober, Johanna
    Schaefer, Vanessa
    Krichbaum, Michael
    Haak, Thomas
    Ziegler, Ralph
    Heinemann, Lutz
    Rieger, Cosima
    Bingol, Ezgi
    Kulzer, Bernhard
    Silbermann, Stephan
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2024,
  • [10] Comparison of the effects of twice-daily exenatide and insulin on carotid intima-media thickness in type 2 diabetes mellitus patients: a 52-week randomized, open-label, controlled trial
    Zhang, Jie
    Xian, Tong-Zhang
    Wu, Ming-Xiao
    Li, Chen
    Pan, Qi
    Guo, Li-Xin
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
12345